4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-055974
Chief Financial Officer sold 23,400 shares at an average $61.41 ($1,437,010)
- Chief Financial Officer acquired 23,400 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2025-05-30 | Option exercise 10b5-1 | +23,400 | $6.88 | $160,992 | 133,329 | D |
| Smith Hunter C Chief Financial Officer | 2025-05-30 | Sale 10b5-1 | −4,407 | $60.93 | $268,515 | 128,922 | D |
| Smith Hunter C Chief Financial Officer | 2025-05-30 | Sale 10b5-1 | −18,993 | $61.52 | $1,168,495 | 109,929 | D |
| Derivatives | |||||||
| Smith Hunter C Chief Financial Officer | 2025-05-30 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −23,400 | 77,194 | D | ||
| Open-market sales · 23,400 sh · avg $61.41 · $1,437,010 | |||||||
Loading xslF345X05/tm2516959-1_4seq1.xml…